4,4-Dimethyl-2-pentadecyloxazol-5(4H)-one, 97.0%, 250mg

ETHYL 5-CHLOROPYRIMIDINE-2-CARBOXYLATE, 95.0%, 100mg

6-Methyl-quinolin-5-ylamine, 95%, 10g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,50 µm, 1 Stück

(S)-TERT-BUTYL 2-(TERT-BUTOXYCARBONYLAMINO)-4-MERCAPTOBUTANOATE, 97%, 100mg

(R)-2-((6R,8R)-7,7-Dimethyl-5,6,7,8-tetrahydro-6,8-methanoquinolin-2-yl)-4-phenyl-4,5-dihydrooxazole, 98%, 1g

1-Methyl-1-cyclohexanecarbonyl chloride, 97.0%, 250mg

(1-Isopentyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 100mg

Ethyl 3-amino-3-(4-bromo-2-methylphenyl)propanoate, HCl, 97%, 1g

N-(17-Hydroxy-3,6,9,12,15-pentaoxaheptadecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 100mg

(1,2-Dihydroacenaphthylen-5-yl)boronic acid, 95.0%, 5g

2-(6-Fluoropyridin-2-yl)acetic acid, 95.0%, 250mg

1H-indazol-4-yl-4-boronic acid, 98%, 250mg